Clinical characteristics and phenotypes of inflammatory bowel disease in Northern Central America: initial results from the Northern Central America Inflammatory Bowel Disease Registry
Open Access
- 5 October 2026
- journal article
- Published by Oxford University Press (OUP) in Crohn’s & Colitis 360
- Vol. 8 (4)
Abstract
Background: Inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC), Crohn’s disease (CD), and IBD unclassified (IBDU), affects over 7 million people worldwide. While incidence has plateaued in higher-income countries, it continues to rise in lower- and middle-income regions, including Latin America. Data from northern Central America remain scarce. Aim: To characterize the clinical and phenotypic profile of IBD in Honduras, El Salvador, and Guatemala. Methods: The Inflammatory Bowel Disease in Northern Central America Research and Epidemiological Study (IBD-NCARES) was a multinational, multicenter descriptive study spanning 15 years. Cases were identified using ICD-10 codes and confirmed by chart review. Sociodemographic, behavioral, and clinical variables were collected. Results: Among 277 patients, UC was the predominant subtype (57.8%), highest in Honduras (71.4%). CD accounted for 11.9% of cases, with greater frequency in Honduras (25.7%). IBDU was frequent in El Salvador (40.3%) and Guatemala (38.2%) compared with Honduras (2.9%). Delayed diagnosis (>1 year) occurred in 35% of UC and 60.6% of CD patients. Complicated CD was observed in 54.5% (B2 30.3%; B3 24.2%). Extraintestinal manifestations included vascular (18.2%) and hepatic/pancreatic (9.1%) complications. Most patients received 5-aminosalicylates or systemic steroids. Only 5.1% of the overall cohort received advanced therapies. Conclusion: This first multinational study of IBD in northern Central America highlights UC predominance, high rates of IBDU (likely inflated by incomplete diagnostics), frequent diagnostic delay, and limited use of advanced therapies. These findings underscore the need for regional registries, improved diagnostic capacity, and expanded therapeutic resources.Keywords
This publication has 20 references indexed in Scilit:
- The four epidemiological stages in the global evolution of inflammatory bowel diseaseNature Reviews Gastroenterology & Hepatology, 2020
- Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: A Systematic ReviewClinical Gastroenterology and Hepatology, 2020
- The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet Gastroenterology & Hepatology, 2020
- Global burden of inflammatory bowel diseaseThe Lancet Gastroenterology & Hepatology, 2020
- Evolving Epidemiology of IBDCurrent Gastroenterology Reports, 2019
- Inflammatory Bowel Disease in Latin America: A Systematic ReviewValue in Health Regional Issues, 2018
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studiesThe Lancet, 2017
- Incidence and Prevalence of Crohn’s Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010Clinical Gastroenterology and Hepatology, 2017
- Articular manifestations in inflammatory bowel disease patients: A prospective studyDigestive and Liver Disease, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009